HomeGreater Than Icon
Dr Lal Pathlabs LtdGreater Than Icon
Dr Lal Pathlabs Ltd Financials
Company Logo

Dr Lal Pathlabs Ltd Financial Statement

Dr Lal Pathlabs Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue605.90
Operating Expense399.40
Net Profit135.20
Net Profit Margin22.31
Earning Per Share16.24
EBIDTA202.60
Effective Tax Rate21.40
Invest in Dr Lal Pathlabs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Dr Lal Pathlabs Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1,966.76
Operating Expenses Annual1,407.52
Operating Profit Annual619.35
Interest Annual26.84
Depreciation39.21
Net Profit Annual384.37
Tax Annual131.60

Dr Lal Pathlabs Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning220.32
Cash Flow from Operations477.60
Cash Flow from Investing31.91
Cash Flow from Financing-404
Cash Flow at the End325.83

Dr Lal Pathlabs Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)31.49
PBIT Margin (%)27.60
PBT Margin (%)26.57
Net PROFIT Margin (%)19.54
Return On Networth / Equity (%)21.42
Return On Networth /Employed (%)25.77
Return On Assets (%)18.18
Total Debt / Equity (X)0.12
Asset Turnover Ratio (%)0.93

Dr Lal Pathlabs Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual310.67
Total Current Assets Annual920.55
Non Current Assets Annual1,494.89
Total Shareholders Funds Annual1,899.66
Total Assets Annual2,415.44

Dr Lal Pathlabs Ltd Earning Calls

EPS (INR)

Expected

15.45

Reported

15.52

Surprise

0.45%

Jun 2024

EPS beaten by 0.45%

Mar 2024

EPS beaten by 0.39%

Dec 2023

EPS beaten by 0.10%

Get Your FAQs Right

As of Nov 22, 2024, Dr Lal Pathlabs Ltd has a market capitalization of 18,888.12 Cr. Value Research classifies it as a Large-Cap company.
Yes, Dr Lal Pathlabs Ltd is debt-free with a debt-to-equity ratio of 0.12.
In FY 2023 , Dr Lal Pathlabs Ltd recorded a total revenue of approximately 1,966.80 Cr marking a significant milestone in the company's financial performance.
Dr Lal Pathlabs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.0% annually, respectively..
Dr Lal Pathlabs Ltd's current PE ratio is 49.14.
Dr Lal Pathlabs Ltd's ROCE averaged 23.6% from the FY ending March 2022 to 2024, with a median of 24.8%. It peaked at 25.5% in March 2024, reflecting strong capital efficiency over the period..
Dr Lal Pathlabs Ltd's latest EBIT is Rs. 542.80 Cr, surpassing the average EBIT of Rs. 485.87 Cr over the 5 years..